Last updated: August 27, 2025
Introduction
Israel Patent IL228162 pertains to a patent centered on novel pharmaceutical compositions or formulations. As a vital component within the global drug innovation landscape, understanding its scope, claims, and positioning within the patent environment is critical for stakeholders such as pharmaceutical companies, legal professionals, and market analysts. This comprehensive assessment elucidates the patent's breadth, specific claims, potential overlaps with existing patents, and its strategic implications.
Patent Overview and Technical Synopsis
Patent IL228162 was filed in Israel and possibly corresponds to applications filed under patent families in other jurisdictions or relates to drug compositions, formulations, or methods of use involving specific active ingredients. While the full patent document details are not provided here, typical pharmaceutical patents of this nature generally focus on:
- Novel active compound combinations
- Innovative delivery mechanisms
- Extended stability or bioavailability properties
- Specific methods for manufacturing or use
Given the nature of Israel's patent framework—aligning with international standards such as the TRIPS Agreement and the European Patent Convention—the scope often revolves around inventive steps in drug formulations or methodologies.
Scope of Patent IL228162
1. Broadness of Claims
Typically, pharmaceutical patents like IL228162 encompass both independent and dependent claims. The independent claims define the core innovation — often a specific compound, composition, or method — while dependent claims specify additional features or narrow the scope.
- Core Claims: Likely describe a pharmaceutical composition comprising specific active ingredients, possibly in unique ratios or sustained-release forms.
- Dependent Claims: May specify particular excipients, pH conditions, or manufacturing processes enhancing stability, bioavailability, or efficacy.
2. Claim Language and Limitations
- The claims probably specify the chemical structure or class of the active pharmaceutical ingredient(s) (APIs).
- They may include formulations tailored for targeted delivery, such as controlled-release or transdermal systems.
- Specifics around dosage, administration routes, or treatment indications could also be encompassed, broadening the patent’s protective scope.
3. Patent Term and Lifecycle
- The patent’s lifespan, generally 20 years from the filing date, is subject to maintenance and patent office procedural updates.
- Its enforceability depends on the novelty, inventive step, and non-obviousness over prior arts.
Claims Analysis — Key Elements
A. Composition Claims
- Cover range of APIs or their combinations with specific excipients.
- Mixtures designed for improved pharmacokinetics or reduced side effects.
B. Method of Manufacture
- Processes involving specific steps, such as synthesis routes, purification techniques, or formulation methods.
- May include innovative co-crystallization or encapsulation processes.
C. Therapeutic Use Claims
- Encompass methods of administering the composition to treat specific medical conditions.
- These are often auxiliary but can significantly extend patent scope if carefully crafted.
D. Markush Language and Variability
- Use of Markush groups may allow the claim to cover a wide class of similar compounds, increasing scope.
- This can bolster patent robustness but may invite validity challenges if too broad.
Patent Landscape and Strategic Positioning
1. Prior Art and Novelty
- The novelty hinges on the unique combination of APIs or delivery system not previously disclosed.
- Prior art searches should focus on early filings, academic publications, or other patents in related drug classes.
2. Overlaps and Potential Infringement
- The patent landscape features numerous patents in similar therapeutic areas, especially if targeting well-researched drugs like antineoplastics, antivirals, or treatments for chronic diseases.
- Overlaps may arise with patents covering the same or similar compositions; hence, detailed claim comparison is essential.
3. Freedom to Operate (FTO)
- Executing an FTO analysis involves evaluating existing patents within the jurisdiction and globally, considering cross-claims that might threaten commercialization.
- The strength of IL228162’s claims in preventing copying or in licensing negotiations depends on claim scope and prior art distinctions.
4. Patent Challenges and Validity Risks
- Broad or vague claims, especially if not supported by sufficient data, could be susceptible to invalidation via patent oppositions or litigations.
- Monitoring competitors’ filings and prior art disclosures is integral for strategic defensibility.
Implications for the Pharmaceutical Market
- Market Exclusivity: IL228162 can provide crucial market protection if the patent withstands legal scrutiny.
- Research & Development: Its claims potentially foster further innovation by setting a foundation for derivative formulations or combination therapies.
- Licensing & Partnerships: The patent’s broad scope may attract licensing deals, especially if it covers a blockbuster therapeutic class.
- Legal Considerations: Vigilant patent management and regular audits are essential for maintaining enforceability, particularly against generic challenges or circumventive designs.
Conclusion
Patent IL228162 embodies a strategic element within Israel’s pharmaceutical patent landscape, likely centered on a novel drug composition, method, or formulation. Its scope, contingent upon detailed claim language, offers potentially broad protections but requires periodic assessment against evolving prior art and competitor filings. Its value hinges on the strength of claims, enforcement capabilities, and the competitive landscape's complexity.
Key Takeaways
- Scope Precision: The patent’s robustness depends on well-drafted claims that delineate clear, specific inventive features while balancing breadth for market protection.
- Landscape Positioning: Proper alignment within the patent landscape, including vigilant prior art searches, enhances its defensibility.
- Strategic Value: IL228162 could serve as a catalyst for licensing, collaborative development, or direct commercialization, contingent on its claims and validity.
- Legal Vigilance: Regular patent monitoring and enforcement are imperative to safeguard market exclusivity.
- Innovation Trajectory: The patent's focus on specific formulations or methods hints at continued R&D efforts, emphasizing formulation optimizations or targeted therapies.
FAQs
1. What is the primary focus of Patent IL228162?
While the exact details are proprietary, it most likely pertains to a novel pharmaceutical composition, formulation, or method related to a specific therapeutic area, aiming to improve efficacy or stability.
2. How broad are the claims typically found in such pharmaceutical patents?
They can range from narrow, specific compositions to broad, generically worded claims encompassing entire classes of compounds or formulations, depending on strategic intent and inventive contribution.
3. How does IL228162 compare to other patents in the pharmaceutical landscape?
Its uniqueness depends on claims specificity, inventive steps, and prior art; comparative analysis with existing patents reveals overlaps or gaps, influencing enforceability and licensing potential.
4. What risks are associated with patent invalidation?
Invalidation risks arise from overly broad claims, insufficient inventive step, or prior art disclosures, which can be exploited through legal challenges, especially in patent opposition proceedings.
5. How can patent holders maximize the value of IL228162?
Through strategic claim scope management, continuous monitoring for infringers, timely enforcement actions, and leveraging the patent in licensing and strategic partnerships.
References
[1] Israel Patent Office. "Patent Examination Guidelines." Israel Patent Law & Procedures.
[2] World Intellectual Property Organization (WIPO). "Patent Search and Examination."
[3] European Patent Office (EPO). "Guidelines for Examination."
[4] Patent Landscape Reports: Pharmaceutical Patents in Israel, 2022.
[5] Recent legal judgments related to pharmaceutical patents in Israel.
